5-HT6 receptor antagonists improve performance in an attentional set shifting task in rats
- First Online:
- 330 Downloads
Rationale and objective
Performance on the Wisconsin Card Sorting Test (WCST), which requires patients to ‘shift attention’ between stimulus dimensions (sorting categories), is impaired in diseases such as schizophrenia. The rat attentional set shifting task is an analogue of the WCST. Given that 5-HT6 receptor antagonists improve cognitive performance and influence cortical neurochemistry in rats, the present study investigated the effects of 5-HT6 receptor antagonists upon attentional set shifting in rats.
Rats were tested in this paradigm following sub-chronic SB-399885-T or SB-271046-A (both 10 mg kg−1 bid, p.o. for 8 days prior to testing and either 4 or 2 h prior to testing on day 9, respectively). Rats were trained to dig in baited bowls for a food reward and to discriminate based on odour or digging media (Habituation, day 8). In a single session (day 9), rats performed a series of discriminations, including reversals (REV), intra-dimensional (ID) and extra-dimensional (ED) shifts.
Neither compound altered performance during Habituation. On the test day, both SB-399885-T and SB-271046-A reduced the total trials to reach criterion and the total errors made when data were collapsed across all discriminations (P<0.05–0.01). Further, both compounds significantly reduced the trials to criterion for REV-1 (P<0.05–0.01) and abolished the ID/ED shift. SB-399885-T, but not SB-271046-A, reduced trials required to complete the ED shift (P<0.05) and the number of errors made during completion of the ID (P<0.05) and ED shifts (P<0.01).
5-HT6 receptor antagonists improved performance in the attentional set shifting task and may have therapeutic potential in the treatment of disorders where cognitive deficits are a feature, including schizophrenia.
KeywordsSB-271046-A SB-399885-T Intra-dimensional shift (ID) Extra-dimensional shift (ED) Wisconsin Card Sorting Task (WCST) Cognition
- Bentley JC, Sleight AJ, Marsden CA, Fone KCF (1997) 5-HT6 antisense oligonucleotide i.c.v. affects rat performance in the water maze and feeding. J Psychopharmacol 11:A64Google Scholar
- Bromidge SM, Brown AM, Clarke SE, Dodgson K, Gager T, Grassam HL, Jeffrey PM, Joiner GF, King FD, Middlemiss DN, Moss SF, Newman H, Riley G, Routledge C, Wyman P (1999) 5-Chloro-N-(4-methoxy-3-piperazin-1-yl-phenyl)-3-methyl-2-benzothiophenesulfonamide (SB-271046): a potent, selective, and orally bioavailable 5-HT6 receptor antagonist. J Med Chem 42(2):202–205CrossRefPubMedGoogle Scholar
- Foley AG, Murphey KJ, Hirst WD, Gallagher HC, Hagan JJ, Upton N, Walsh FS, Regan CM (2004) The 5-HT6 receptor antagonist SB-271046 reverses scopolamine-disrupted consolidation of a passive avoidance task and ameliorates spatial task deficits in aged rats. Neuropsychopharmacology 29(1):93–100CrossRefPubMedGoogle Scholar
- Hamon M, Doucet E, Lefevre K, Miquel MC, Lanfumey L, Insausti R, Frechilla D, Del Rio J, Verge D (1999) Antibodies and antisense oligonucleotide for probing the distribution and putative functions of central 5-HT6 receptor. Neuropsychopharmacology 21:68–76Google Scholar
- Hatcher PD, Brown VJ, Tait DS, Jones DNC (2002) 5-HT6 receptor antagonists improve performance in an attentional set shifting task. J Psychopharmacol 16(3):A16Google Scholar
- Hirst WD, Stean TO, Rogers DC, Sunters D, Pugh P, Moss SF, Bromidge SM, Riley G, Smith DR, Barlett S, Heidbreder CA, Atkins AR, Lacroix LP, Dawson LA, Foley AG, Regan CM, Upton N. SB-399885 is a potent, selective 5-HT6 receptor antagonist active in rat water maze and novel object recognition models, Br J Pharmacol (personal communication)Google Scholar
- Lindner MD, Hodges DB, Hogan JB, Orie AF, Corsa JA, Barten DM, Polson C, Robertson BJ, Guss VL, Gillman KW, Starrett JE, Gribkoff VK (2003) An assessment of the effects of serotonin 6 (5-HT6) receptor antagonists in rodent models of learning. J Pharmacol Exp Ther 307(2):682–691CrossRefPubMedGoogle Scholar
- Regan CM, Foley AG, Murphy KJ, Hirst WD, Gallagher HC, Hagan JJ, Upton N, Walsh FS (2003) The 5-HT6 receptor antagonists SB-271046 and SB-399885 increase basal and learning induced NCAM-polysialylation in the rat dentate gyrus. Society for Neuroscience No. 835.21Google Scholar
- Riemer C, Borroni E, Levet-Treafit B, Martin JR, Poli S, Porter RHP, Bos M (2003) Influence of the 5-HT6 receptor on acetylcholine release in the cortex: pharmacological characterisation 4-(2-Bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine, a potent and selective 5-HT6 receptor antagonist. J Med Chem 46:1273–1276CrossRefPubMedGoogle Scholar
- Roberts AC, Robbins TW, Everitt BJ (1988) The effects of intradimensional and extra-dimensional shifts on visual discrimination learning in humans and non-human primates. Q J Exp Psychol 40B:321–341Google Scholar
- Roth BL, Sheffler DJ, Kroeze WK (2004) Magic shotgun versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nat Rev 3:353–359Google Scholar
- Woolley ML, Marsden CA, Sleight AJ, Fone KCF (2000) Reversal of a scopolamine-induced deficit in object discrimination by a selective 5-HT6 receptor antagonist, RO-06790, in rats. Br J Pharmacol 129:64PGoogle Scholar